NCT05874284

Brief Summary

The goal of this \[type of study: randomized controlled clinical trial\] is to \[Determining the effect of prolotherapy use on the wound care process\]. The main question it aims to answer is: • \[The use of proliferative substances in the care of 1st, 2nd and 3rd stage pressure injuries has a positive effect on the wound healing period\]. Participants will \[in patients with pressure injuries, wound irrigation with saline and wound irrigation with gelofusin were applied\]. Researchers will compare \[depth, length and width of the wound\].

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at P25-P50 for early_phase_1

Timeline
Completed

Started Jun 2023

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 13, 2023

Completed
11 days until next milestone

First Posted

Study publicly available on registry

May 24, 2023

Completed
17 days until next milestone

Study Start

First participant enrolled

June 10, 2023

Completed
5 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 15, 2023

Completed
5 days until next milestone

Study Completion

Last participant's last visit for all outcomes

June 20, 2023

Completed
Last Updated

February 26, 2024

Status Verified

February 1, 2024

Enrollment Period

5 days

First QC Date

May 13, 2023

Last Update Submit

February 23, 2024

Conditions

Keywords

pressure injuryproliferativewound care

Outcome Measures

Primary Outcomes (1)

  • wound healing time

    The change in wound healing time will be examined.

    3 days

Study Arms (2)

Experimental group

EXPERIMENTAL

The nasopharyngeal suction with positive pressure method was employed in the sample group. In this method, the infant's head is turned to the side, 1-2 ml of PS is injected into the nostril with a syringe, and then positive pressure is exerted with the help of the end of the oxygen hose from the same nostril, with oxygen or air supply at 5-8 lt/min (if the baby requires oxygen, using an oxygen source) and the nasopharyngeal secretions are removed from the nostril into which PS has been not injected. The oxygen hose is held one centimetre away from the infant's nostril. The researchers prepared a guideline for nasopharyngeal suction with positive pressure based on the literature.

Drug: Gelofusin

conroul group

NO INTERVENTION

The nasopharyngeal suction with negative pressure method was employed in the control group in this study. In this method, the nasal secretions were softened with 1-2 ml of physiological saline (PS), and then negative pressure suction was performed using a pine-tipped suction set. In the literature, neonatal aspiration pressure is defined as 60-100 mmHg. In this study, the suction pressure was kept between 60 and 80 mmHg, and no suction lasted for more than 15 seconds.

Interventions

In the experimental group, the wound will be washed with gelofusine as prolotherapy, and the wound will be closed with sterile sponge and fixative tape. In the control group, the wound will be covered with sterile sponge and fixative tape by washing with physiological saline.

Also known as: there is no other name
Experimental group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients with 1st, 2nd and 3rd stage pressure injuries
  • Patients over 18 years of age
  • Patients who volunteered to participate in the study

You may not qualify if:

  • Patients without 1st, 2nd and 3rd stage pressure injuries
  • Patients under 18 years of age
  • Patients who did not volunteer to participate in the study
  • Patients allergic to gelofusin solution

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Fenerbahce University

Istanbul, Atasehir, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Pressure Ulcer

Interventions

succinylated gelatin

Condition Hierarchy (Ancestors)

Skin UlcerSkin DiseasesSkin and Connective Tissue Diseases

Study Design

Study Type
interventional
Phase
early phase 1
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
SUPPORTIVE CARE
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Research Assistant

Study Record Dates

First Submitted

May 13, 2023

First Posted

May 24, 2023

Study Start

June 10, 2023

Primary Completion

June 15, 2023

Study Completion

June 20, 2023

Last Updated

February 26, 2024

Record last verified: 2024-02

Data Sharing

IPD Sharing
Will not share

Locations